Rivaroxaban – a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases

by Ewa Haładyj, Marzena Olesińska
Published 2016-07-01

Do we still need renal biopsy in lupus nephritis?

by Ewa Haładyj, Ricard Cervera
Published 2016-06-01

Repeat renal biopsy in lupus nephritis – unnecessary harm and risk of complications or important diagnostic tool with clinical consequences?

by Ewa Haładyj, Ricard Cervera
Published 2016-06-01

Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome

by Ewa Haładyj, Agnieszka Paradowska-Gorycka, Anna Felis-Giemza, Marzena Olesińska
Published 2016-10-01

RORC2 Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis

by Agnieszka Paradowska-Gorycka, Barbara Stypinska, Andrzej Pawlik, Katarzyna Romanowska-Prochnicka, Ewa Haladyj, Malgorzata Manczak, Marzena Olesinska
Published 2016-04-01

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis.

by Agnieszka Paradowska-Gorycka, Andrzej Pawlik, Katarzyna Romanowska-Prochnicka, Ewa Haladyj, Damian Malinowski, Barbara Stypinska, Malgorzata Manczak, Marzena Olesinska
Published 2016-01-01

FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis.

by Agnieszka Paradowska-Gorycka, Anna Sowinska, Andrzej Pawlik, Damian Malinowski, Barbara Stypinska, Ewa Haladyj, Katarzyna Romanowska-Prochnicka, Marzena Olesinska
Published 2017-01-01

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases

by Piotr Wojdasiewicz, Anna Wajda, Ewa Haładyj, Katarzyna Romanowska-Próchnicka, Anna Felis-Giemza, Jolanta Nałęcz-Janik, Marcela Walczyk, Marzena Olesińska, Beata Tarnacka, Agnieszka Paradowska-Gorycka
Published 2019-06-01